DAVI · NASDAQ · Healthcare · $42.0M
$1.68-37.5%vs prev closeclose of 2026-10-30 · not real-time
Some axes lack data (–)
A summary of valuation factors — not a buy recommendation. You decide.
| Company | PER | PBR | ROE | Div | Score |
|---|---|---|---|---|---|
| Davion Healthcare Plc | – | 0.6 | -1% | 0.0% | – |
| Harvard Bioscience Inc. | – | 5.5 | -90% | 0.0% | 50 |
| GridAI Technologies Corp. | – | – | – | 0.0% | 35 |
| Precipio Inc. | – | 2.2 | -9% | 0.0% | 43 |
| Daxor Corporation | 8.4 | 1.0 | 14% | 0.0% | 39 |
| Nortech Systems Incorporated | 28.1 | 0.8 | 3% | 0.0% | 53 |
Same sector, nearest by market cap · – = no data (value traps excluded)
The chart (long-term trend, Ichimoku cloud) is for observation only — not a buy or sell signal.
A highlight of the key metrics detailed below.
Top-tier in 0 of 1 evaluated strategies
Ranks within the US market — tap to open that ranking (ranks are per market).
Past returns — they do not guarantee future results.
A Japanese trend tool. Price above the 'cloud' is supportive; below is weak. A strong uptrend doesn't mean it's cheap — stocks that have run up are usually more expensive.